Category: Cardiac Implants
Medtronic's cardiac and vascular group president, Michael Coyle, questions CardioMEMS' implantable heart monitor, citing Medtronic's experience with its now-abandoned Chronicle monitor.
The Champion implantable heart monitor made by CardioMEMS might not prove as cost-effective as a non-invasive approach, at least according to Medtronic (NYSE:MDT) cardiac and vascular group president Michael Coyle.
German device maker Transcatheter Technologies reports positive early findings from a study of its "game-changer" Trinity transcatheter aortic valve implantation system.
Emerging medical device maker Transcatheter Technologies GmbH unveiled an early look at clinical results for its 3rd-generation Trinity transcatheter aortic valve implantation platform, which the company calls "the world's 1st 'truly repositionable' and, therefore, best TAVI system."
MassDevice.com's Predictive Intelligence survey aims to better anticipate and plan for major market events. Take our survey about the upcoming FDA panel meeting on Boston Scientific's Watchman anti-stroke heart implant and gain exclusive access to our Predictive Intelligence results.
MassDevice.com's new Predictive Intelligence service aims to better anticipate and plan for major market events.
AtriCure says the FDA granted an investigational device exemption for a clinical trial of its AtriClip left atrial appendage exclusion device to gauge its utility in preventing stroke in patients with atrial fibrillation.
AtriCure (NSDQ:ATRC) said today that the FDA approved the launch of a clinical trial to examine whether its AtriClip device can be used to prevent strokes in patients with atrial fibrillation.
An FDA advisory panel is slated to meet next month to discuss whether to recommend approval for Boston Scientific's anti-stroke Watchman heart implant.
Boston Scientific (NYSE:BSX) won a date with an FDA advisory panel for its Watchman heart implant after the anti-stroke device met 2 of 3 endpoints in a clinical trial.
Middle Peak Medical adds $3 million from Edwards Lifesciences and other investors to its Series A round.
Middle Peak Medical said it added $3 million from Edwards Lifesciences (NYSE:EW) and other investors to its Series A round, taking the total raise to $11 million.
German medical device maker Transcatheter Technologies GmbH announces 1st-in-man implantation of its repositionable Trinity transcatheter aortic valve system, treading into territory already marked by medtech giants Medtronic and St. Jude Medical.
MASSDEVICE ON CALL — Germany-based medical device company Transcatheter Technologies GmbH is making a bold stride into the transcatheter aortic valve implantation space, announcing 1st-in-man implantation of a device it says it intends to be the "the world's best repositionable heart valve."